BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33781852)

  • 1. Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy.
    Oh JK; Lee SH; Lee SA; Kang DY; Lee S; Kim HJ; Ahn JM; Kim JB; Park DW; Song JM; Choo SJ; Kang DH; Song JK; Park SJ; Kim DH
    Int J Cardiol; 2021 Jun; 332():60-66. PubMed ID: 33781852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.
    Chau KH; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
    J Am Coll Cardiol; 2020 May; 75(19):2446-2458. PubMed ID: 32408979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations.
    Lindman BR; Stewart WJ; Pibarot P; Hahn RT; Otto CM; Xu K; Devereux RB; Weissman NJ; Enriquez-Sarano M; Szeto WY; Makkar R; Miller DC; Lerakis S; Kapadia S; Bowers B; Greason KL; McAndrew TC; Lei Y; Leon MB; Douglas PS
    JACC Cardiovasc Interv; 2014 Jun; 7(6):662-73. PubMed ID: 24947722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.
    Gonzales H; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
    JACC Cardiovasc Interv; 2020 Jun; 13(11):1329-1339. PubMed ID: 32499024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversibility of Cardiac Function Predicts Outcome After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis.
    Sato K; Kumar A; Jones BM; Mick SL; Krishnaswamy A; Grimm RA; Desai MY; Griffin BP; Rodriguez LL; Kapadia SR; Obuchowski NA; Popović ZB
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28698259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of residual left ventricular hypertrophy and systolic dysfunction in aortic stenosis following transcatheter aortic valve replacement.
    Pedersen ALD; Povlsen JA; Rasmussen VG; Frederiksen CA; Christiansen EH; Terkelsen CJ; Vase H; Poulsen SH
    Int J Cardiovasc Imaging; 2023 Jan; 39(1):13-22. PubMed ID: 36598683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of transcatheter aortic valve replacement on left ventricular hypertrophy, diastolic dysfunction and quality of life in patients with preserved left ventricular function.
    Dahiya G; Kyvernitakis A; Joshi AA; Lasorda DM; Bailey SH; Raina A; Biederman RWW; Kanwar MK
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):485-492. PubMed ID: 32902782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
    JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of arterial stiffness following transcatheter aortic valve replacement.
    Tanaka T; Asami M; Yahagi K; Ninomiya K; Okuno T; Horiuchi Y; Komiyama K; Tanaka J; Yokozuka M; Miura S; Aoki J; Tanabe K
    J Cardiol; 2021 Jul; 78(1):37-43. PubMed ID: 33516637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women had favourable reverse left ventricle remodelling after TAVR.
    Chen SC; Leu HB; Chang HH; Chen IM; Chen PL; Lin SM; Chen YH
    Eur J Clin Invest; 2020 Jan; 50(1):e13183. PubMed ID: 31691961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of paravalvular regurgitation on the mid-term outcome after transcatheter and surgical aortic valve replacement.
    Laakso T; Laine M; Moriyama N; Dahlbacka S; Airaksinen J; Virtanen M; Husso A; Tauriainen T; Niemelä M; Mäkikallio T; Valtola A; Eskola M; Juvonen T; Biancari F; Raivio P
    Eur J Cardiothorac Surg; 2020 Dec; 58(6):1145-1152. PubMed ID: 33057657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
    Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Left Ventricle and Clinical Outcomes After Transcatheter Aortic Valve Replacement.
    Saito T; Inohara T; Yoshijima N; Yashima F; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
    J Am Heart Assoc; 2021 Apr; 10(7):e019543. PubMed ID: 33749309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.
    Freitas-Ferraz AB; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Annabi MS; Pelletier-Beaumont E; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2020 Mar; 13(5):567-579. PubMed ID: 32061600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of severe aortic stenosis patients combined with diabetes mellitus after transcatheter aortic valve replacement and short-term outcome.
    Su W; Tai S; Huang Y; Hu X; Zhou S; Fang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):309-318. PubMed ID: 35545323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement.
    Ito N; Zen K; Takahara M; Tani R; Nakamura S; Fujimoto T; Takamatsu K; Yashige M; Kadoya Y; Yamano M; Yamano T; Nakamura T; Yaku H; Matoba S
    ESC Heart Fail; 2023 Apr; 10(2):1336-1346. PubMed ID: 36725669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT-Defined Prosthesis-Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement.
    Mooney J; Sellers SL; Blanke P; Pibarot P; Hahn RT; Dvir D; Douglas PS; Weissman NJ; Kodali SK; Thourani VH; Jilaihawi H; Khalique O; Smith CR; Kueh SH; Ohana M; Grover R; Naoum C; Crowley A; Jaber WA; Alu MC; Parvataneni R; Mack M; Webb JG; Leon MB; Leipsic JA
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1578-1587. PubMed ID: 28734891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac structural changes after transcatheter aortic valve replacement: systematic review and meta-analysis of cardiovascular magnetic resonance studies.
    Mehdipoor G; Chen S; Chatterjee S; Torkian P; Ben-Yehuda O; Leon MB; Stone GW; Prince MR
    J Cardiovasc Magn Reson; 2020 Jun; 22(1):41. PubMed ID: 32475350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical aortic valve replacement provides better left ventricular mass regression than transcatheter aortic valve replacement in patients with small aortic annulus.
    Nishigawa K; Onga Y; Uemura K; Shimokawa T; Fukui T
    Gen Thorac Cardiovasc Surg; 2023 Mar; 71(3):167-174. PubMed ID: 35904726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.
    Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.